Suppr超能文献

基于聚合物-表面活性剂体系的无定形固体分散体:伊曲康唑的沉淀抑制与生物利用度提高

Polymer⁻Surfactant System Based Amorphous Solid Dispersion: Precipitation Inhibition and Bioavailability Enhancement of Itraconazole.

作者信息

Feng Disang, Peng Tingting, Huang Zhengwei, Singh Vikramjeet, Shi Yin, Wen Ting, Lu Ming, Quan Guilan, Pan Xin, Wu Chuanbin

机构信息

School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.

出版信息

Pharmaceutics. 2018 Apr 24;10(2):53. doi: 10.3390/pharmaceutics10020053.

Abstract

The rapid release of poorly water-soluble drugs from amorphous solid dispersion (ASD) is often associated with the generation of supersaturated solution, which provides a strong driving force for precipitation and results in reduced absorption. Precipitation inhibitors, such as polymers and surfactants, are usually used to stabilize the supersaturated solution by blocking the way of kinetic or thermodynamic crystal growth. To evaluate the combined effect of polymers and surfactants on maintaining the supersaturated state of itraconazole (ITZ), various surfactants were integrated with enteric polymer hydroxypropyl methylcellulose acetate succinate (HPMC AS) to develop polymer⁻surfactant based solid dispersion. The supersaturation stability was investigated by in vitro supersaturation dissolution test and nucleation induction time measurement. Compared to the ASD prepared with HPMC AS alone, the addition of d-alpha-tocopheryl polyethylene glycol 1000 succinate (TPGS) exhibited a synergistic effect on precipitation inhibition. The results indicated that the TPGS not only significantly reduced the degree of supersaturation which is the driving force for precipitation, but also provided steric hindrance to delay crystal growth by absorbing onto the surface of small particles. Subsequently, the formulations were evaluated in vivo in beagle dogs. Compared with commercial product Sporanox, the formulation prepared with HPMC AS/TPGS exhibited a 1.8-fold increase in the AUC (0⁻24 h) of ITZ and a 1.43-fold increase of hydroxyitraconazole (OH-ITZ) in the plasma. Similarly, the extent of absorption was increased by more than 40% when compared to the formulation prepared with HPMC AS alone. The results of this study demonstrated that the ASD based on polymer⁻surfactant system could obviously inhibit drug precipitation in vitro and in vivo, which provides a new access for the development of ASD for poorly water-soluble drug.

摘要

难溶性药物从无定形固体分散体(ASD)中的快速释放通常与过饱和溶液的形成有关,而过饱和溶液会产生强烈的沉淀驱动力,导致吸收减少。沉淀抑制剂,如聚合物和表面活性剂,通常用于通过阻断动力学或热力学晶体生长的途径来稳定过饱和溶液。为了评估聚合物和表面活性剂对维持伊曲康唑(ITZ)过饱和状态的联合作用,将各种表面活性剂与肠溶聚合物醋酸琥珀酸羟丙基甲基纤维素(HPMC AS)整合,以开发基于聚合物-表面活性剂的固体分散体。通过体外过饱和溶解试验和成核诱导时间测量来研究过饱和稳定性。与单独用HPMC AS制备的ASD相比,添加d-α-生育酚聚乙二醇1000琥珀酸酯(TPGS)对沉淀抑制表现出协同作用。结果表明,TPGS不仅显著降低了作为沉淀驱动力的过饱和度,还通过吸附在小颗粒表面提供空间位阻来延迟晶体生长。随后,在比格犬体内对制剂进行了评估。与市售产品斯皮仁诺相比,用HPMC AS/TPGS制备的制剂的ITZ血浆AUC(0⁻24小时)增加了1.8倍,羟基伊曲康唑(OH-ITZ)增加了1.43倍。同样,与单独用HPMC AS制备的制剂相比,吸收程度增加了40%以上。本研究结果表明,基于聚合物-表面活性剂系统的ASD在体外和体内均可明显抑制药物沉淀,为难溶性药物ASD的开发提供了新途径。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验